Global Biotechnology

Contents

Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Covance Inc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Global biotechnology market value: $ billion, 2007–11
Table 2: Global biotechnology market category segmentation: $ billion, 2011
Table 3: Global biotechnology market geography segmentation: $ billion, 2011
Table 4: Global biotechnology market value forecast: $ billion, 2011–16
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Covance Inc.: key facts
Table 9: Covance Inc.: key financials ($)
Table 10: Covance Inc.: key financial ratios
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: key financials ($)
Table 13: Merck & Co., Inc.: key financial ratios
Table 14: F. Hoffmann-La Roche Ltd: key facts
Table 15: F. Hoffmann-La Roche Ltd: key financials ($)
Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 17: F. Hoffmann-La Roche Ltd: key financial ratios

LIST OF FIGURES

Figure 1: Global biotechnology market value: $ billion, 2007–11
Figure 2: Global biotechnology market category segmentation: % share, by value, 2011
Figure 3: Global biotechnology market geography segmentation: % share, by value, 2011
Figure 4: Global biotechnology market value forecast: $ billion, 2011–16
Figure 5: Forces driving competition in the global biotechnology market, 2011
Figure 6: Drivers of buyer power in the global biotechnology market, 2011
Figure 7: Drivers of supplier power in the global biotechnology market, 2011
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market, 2011
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market, 2011
Figure 10: Drivers of degree of rivalry in the global biotechnology market, 2011
Figure 11: Amgen, Inc.: revenues & profitability
Figure 12: Amgen, Inc.: assets & liabilities
Figure 13: Covance Inc.: revenues & profitability
Figure 14: Covance Inc.: assets & liabilities
Figure 15: Merck & Co., Inc.: revenues & profitability
Figure 16: Merck & Co., Inc.: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities